iBio, Inc. (IBIO): Price and Financial Metrics
GET POWR RATINGS... FREE!
IBIO Stock Summary
- IBIO INC's market capitalization of $57,813,890 is ahead of just 13.66% of US-listed equities.
- The capital turnover (annual revenue relative to shareholder's equity) for IBIO is 0.04 -- better than only 10.03% of US stocks.
- With a price/sales ratio of 20.55, IBIO INC has a higher such ratio than 93.63% of stocks in our set.
- Stocks that are quantitatively similar to IBIO, based on their financial statements, market capitalization, and price volatility, are SCWX, BASE, CTSO, ATEN, and VTEX.
- Visit IBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.ibioinc.com.
IBIO Valuation Summary
- In comparison to the median Healthcare stock, IBIO's price/sales ratio is 309.43% higher, now standing at 21.7.
- Over the past 156 months, IBIO's price/sales ratio has gone down 11.2.
Below are key valuation metrics over time for IBIO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| IBIO | 2022-09-01 | 21.7 | 0.8 | -1.8 | -1.6 |
| IBIO | 2022-08-31 | 21.5 | 0.8 | -1.8 | -1.5 |
| IBIO | 2022-08-30 | 21.9 | 0.8 | -1.8 | -1.6 |
| IBIO | 2022-08-29 | 21.9 | 0.8 | -1.8 | -1.6 |
| IBIO | 2022-08-26 | 23.0 | 0.8 | -1.9 | -1.7 |
| IBIO | 2022-08-25 | 24.8 | 0.9 | -2.1 | -1.8 |
IBIO Growth Metrics
- Its 3 year price growth rate is now at -69.32%.
- Its 4 year net income to common stockholders growth rate is now at -255.94%.
- Its 4 year price growth rate is now at -70.97%.
The table below shows IBIO's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-03-31 | 2.813 | -33.203 | -33.286 |
| 2021-12-31 | 1.635 | -34.608 | -28.621 |
| 2021-09-30 | 2.172 | -32.341 | -24.873 |
| 2021-06-30 | 2.371 | -30.064 | -23.467 |
| 2021-03-31 | 3 | -26.705 | -27.121 |
| 2020-12-31 | 2.331 | -23.142 | -24.137 |
IBIO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IBIO has a Quality Grade of D, ranking ahead of 5.38% of graded US stocks.
- IBIO's asset turnover comes in at 0.017 -- ranking 375th of 681 Pharmaceutical Products stocks.
- COLL, COCP, and IRWD are the stocks whose asset turnover ratios are most correlated with IBIO.
The table below shows IBIO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.017 | 0.383 | -0.256 |
| 2021-03-31 | 0.024 | 0.836 | -0.331 |
| 2020-12-31 | 0.023 | 1.000 | -0.317 |
| 2020-09-30 | 0.027 | 1.000 | -0.273 |
| 2020-06-30 | 0.032 | 1.000 | -0.231 |
| 2020-03-31 | 0.036 | 1.000 | -0.271 |
IBIO Stock Price Chart Interactive Chart >
IBIO Price/Volume Stats
| Current price | $0.28 | 52-week high | $1.24 |
| Prev. close | $0.27 | 52-week low | $0.22 |
| Day low | $0.28 | Volume | 58,776 |
| Day high | $0.28 | Avg. volume | 2,308,996 |
| 50-day MA | $0.26 | Dividend yield | N/A |
| 200-day MA | $0.38 | Market Cap | 60.43M |
iBio, Inc. (IBIO) Company Bio
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
Latest IBIO News From Around the Web
Below are the latest news stories about IBIO INC that investors may wish to consider to help them evaluate IBIO as an investment opportunity.
iBio shareholders approve 1-for-25 reverse stock split (IBIO)iBio (IBIO) shareholders have approved the company''s proposal to provide for a 1-for-25 share reverse stock split.Shares are up 7% in Wednesday morning trading.However, an SEC filing… |
Is the iBio Inc. (AMEX:IBIO) stock an investment opportunity?iBio Inc. (IBIO)’s stock is trading at $0.28 at the moment marking a fall of -0.49% from the last session close. As of this writing, shares are priced at -82.54% less than their 52-week high of $1.63, and 28.78% over their 52-week low of $0.22. Based on the past 30-day period, the stock price is … Is the iBio Inc. (AMEX:IBIO) stock an investment opportunity? Read More » |
iBio Inc. (AMEX:IBIO) Shares Rebounded 24.14% From Their Lows – But Can They Continue?In last trading session, iBio Inc. (AMEX:IBIO) saw 1.67 million shares changing hands with its beta currently measuring -4.65. Company’s recent per share price level of $0.29 trading at $0.03 or 8.98% at ring of the bell on the day assigns it a market valuation of $55.62M. That closing price of IBIO’s stock is at … iBio Inc. (AMEX:IBIO) Shares Rebounded 24.14% From Their Lows – But Can They Continue? Read More » |
iBio Inc. (AMEX: IBIO) Has Yet To Win Over Analysts?iBio Inc. (AMEX:IBIO) traded at $0.26 at last check on Tuesday, June 07, made an upward move of 7.22% on its previous day’s price. Looking at the stock we see that its previous close was $0.24 and the beta (5Y monthly) reads -5.38 with the day’s price range being $0.24 – $0.27. In terms of … iBio Inc. (AMEX: IBIO) Has Yet To Win Over Analysts? Read More » |
iBio to Participate in the H.C. Wainwright Global Investment ConferenceBRYAN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming® Manufacturing System, today announced that it will participate virtually in the H.C. Wainwright Global Investment Conference. The hybrid conference will take place May 23-26, 2022. iBio's pre-recorded presentation will be available on demand during the event for all registered attendees. Begin |
IBIO Price Returns
| 1-mo | 14.29% |
| 3-mo | 1.74% |
| 6-mo | -20.90% |
| 1-year | -76.07% |
| 3-year | -55.06% |
| 5-year | -90.34% |
| YTD | -49.00% |
| 2021 | -47.71% |
| 2020 | 321.69% |
| 2019 | -66.80% |
| 2018 | -57.63% |
| 2017 | -55.75% |
Continue Researching IBIO
Want to do more research on iBio Inc's stock and its price? Try the links below:iBio Inc (IBIO) Stock Price | Nasdaq
iBio Inc (IBIO) Stock Quote, History and News - Yahoo Finance
iBio Inc (IBIO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...